Literature DB >> 28232318

Modification of the Psoriatic Arthritis Disease Activity Score (PASDAS).

Philip S Helliwell1,2, Robin Waxman1.   

Abstract

Entities:  

Keywords:  Disease Activity; Outcomes research; Psoriatic Arthritis

Mesh：

Year:  2017        PMID： 28232318     DOI： 10.1136/annrheumdis-2016-211010

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

Review 1.  Measuring Outcomes in Psoriatic Arthritis.

Authors:  Alexis Ogdie; Laura C Coates; Philip Mease
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-10       Impact factor: 4.794

2.  Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.

Authors:  Josef S Smolen; Monika Schöls; Jürgen Braun; Maxime Dougados; Oliver FitzGerald; Dafna D Gladman; Arthur Kavanaugh; Robert Landewé; Philip Mease; Joachim Sieper; Tanja Stamm; Maarten de Wit; Daniel Aletaha; Xenofon Baraliakos; Neil Betteridge; Filip van den Bosch; Laura C Coates; Paul Emery; Lianne S Gensler; Laure Gossec; Philip Helliwell; Merryn Jongkees; Tore K Kvien; Robert D Inman; Iain B McInnes; Mara Maccarone; Pedro M Machado; Anna Molto; Alexis Ogdie; Denis Poddubnyy; Christopher Ritchlin; Martin Rudwaleit; Adrian Tanew; Bing Thio; Douglas Veale; Kurt de Vlam; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2017-07-06       Impact factor: 19.103

3.  Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.

Authors:  L C Coates; D D Gladman; P Nash; O FitzGerald; A Kavanaugh; T K Kvien; L Gossec; V Strand; L Rasouliyan; L Pricop; K Ding; S M Jugl; C Gaillez
Journal:  Arthritis Res Ther       Date:  2018-12-07       Impact factor: 5.156

4.  Determinants of work and social participation in patients with psoriatic arthritis in the Netherlands: an observational study.

Authors:  Tamara W van Hal; Michelle L M Mulder; Mark H Wenink; Johanna E Vriezekolk
Journal:  BMC Rheumatol       Date:  2022-08-17

5.  Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA).

Authors:  Michelle L M Mulder; Johanna E Vriezekolk; Nathan den Broeder; Elien A M Mahler; Philip S Helliwell; Frank H J van den Hoogen; Alfons A den Broeder; Mark H Wenink
Journal:  Trials       Date:  2020-02-10       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.